This study looks at patients with atopic dermatitis (AD), a skin condition causing red, itchy patches. It focuses on those starting or changing treatments that affect the whole body, known as systemic treatments. It's not testing new drugs but observing real-life treatment effects and safety over time. The study lasts 5 years, involving 10 countries, and aims to understand the different needs and experiences of patients with AD.
To join, you must be at least 12 years old, have a confirmed AD diagnosis, and be starting a new systemic treatment like biologics or JAK inhibitors (medicines affecting the immune system). You can't join if you're in another drug trial affecting AD care.
- Duration: The study will last for 5 years.
- Participation: No experimental drugs are involved, just observation.
- Eligibility: Must be 12+ years with a confirmed AD diagnosis.
How understandable was the trial content above?
Hard to understand
Easy to understand